Literature DB >> 16678568

The road to rome.

W Grant Thompson1.   

Abstract

Mesh:

Year:  2006        PMID: 16678568     DOI: 10.1053/j.gastro.2006.03.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  21 in total

1.  Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.

Authors:  Uday C Ghoshal; Philip Abraham; Shobna J Bhatia; Sri Prakash Misra; Gourdas Choudhuri; K D Biswas; Karmabir Chakravartty; Sunil Dadhich; B D Goswami; V Jayanthi; Sunil Kumar; Abraham Koshy; K R Vinay Kumar; Govind Makharia; Sandeep Nijhawan; Nitesh Pratap; Gautam Ray; Sanjeev Sachdeva; Shivaram Prasad Singh; Varghese Thomas; Harsh Udawat
Journal:  Indian J Gastroenterol       Date:  2013-09-03

2.  The therapeutic effect of Xiaopi-I on functional dyspepsia.

Authors:  Hui Li; Zhen-Yu Yang; Yan Li
Journal:  Chin J Integr Med       Date:  2012-02-27       Impact factor: 1.978

3.  Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? - A Rome III Based Prevalence Study of the Korean Medical Students.

Authors:  Hyun Joo Jung; Moo In Park; Won Moon; Seun Ja Park; Hyung Hun Kim; Eun Ji Noh; Gyu Jin Lee; Joo Hoon Kim; Dong Gyu Kim
Journal:  J Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 4.924

4.  Irritable bowel syndrome and other gastrointestinal disorders: evaluating self-medication in an Asian community setting.

Authors:  Chong-Han Kua; Siow-Tian Ng; Reshma Lhode; Stefan Kowalski; Kok-Ann Gwee
Journal:  Int J Clin Pharm       Date:  2012-05-03

5.  Median arcuate ligament syndrome in the pediatric population.

Authors:  Grace Z Mak; Christopher Speaker; Kristen Anderson; Colleen Stiles-Shields; Jonathan Lorenz; Tina Drossos; Donald C Liu; Christopher L Skelly
Journal:  J Pediatr Surg       Date:  2013-11       Impact factor: 2.545

6.  The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.

Authors:  Dong Won Park; Oh Young Lee; Sung Gon Shim; Dae Won Jun; Kang Nyeong Lee; Hye Young Kim; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

7.  The Pharmacological Effects of Benachio-F(®) on Rat Gastrointestinal Functions.

Authors:  Bijay Kumar Poudel; Jae Young Yu; Yong Sam Kwon; Hyoung Geun Park; Miwon Son; Joon Ho Jun; Jeong Ah Kim; Jong Oh Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-07-01       Impact factor: 4.634

Review 8.  STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.

Authors:  Bertram Ottillinger; Martin Storr; Peter Malfertheiner; Hans-Dieter Allescher
Journal:  Wien Med Wochenschr       Date:  2012-12-20

9.  The gut microbiota and irritable bowel syndrome: friend or foe?

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal; Kok-Ann Gwee; Siew C Ng; Eamonn M M Quigley
Journal:  Int J Inflam       Date:  2012-04-22

10.  Gastrointestinal problems in modern wars: clinical features and possible mechanisms.

Authors:  Wei-Feng Wang; Xiao-Xu Guo; Yun-Sheng Yang
Journal:  Mil Med Res       Date:  2015-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.